Article Information
PubMed
Published By
Online ISSN
History
- Received November 3, 2021
- Revision received November 10, 2021
- Accepted November 12, 2021
- Published online November 29, 2021.
Copyright & Usage
© 2021 Rusilowicz-Jones et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
Author Information
- Emma V Rusilowicz-Jones, Conceptualization, Data curation, Formal analysis, Investigation, Funding acquisition, Methodology, Writing—original draft, review, and editing1,*,
- Francesco G Barone, Conceptualization, Data curation, Formal analysis, Investigation, Writing—review and editing1,*,
- Fernanda Martins Lopes, Formal analysis, Investigation2,
- Elezabeth Stephen, Formal analysis, Investigation2,
- Heather Mortiboys, Conceptualization, Supervision, Funding acquisition, Project administration, Writing—review and editing2,
- Sylvie Urbé, Conceptualization, Supervision, Funding acquisition, Visualization, Project administration, Writing—original draft, review, and editing1⇑ and
- Michael J Clague, Conceptualization, Supervision, Funding acquisition, Project administration, Writing—original draft, review, and editing1⇑
- 1Department of Molecular Physiology and Cell Signaling, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK
- 2Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK
- Correspondence: urbe{at}liv.ac.uk
- clague{at}liv.ac.uk
↵* Emma V Rusilowicz-Jones and Francesco G Barone contributed equally to this work
Funding
Wellcome Trust
102172/B/13/ZFG BaroneBristol Myers Squibb and Celgene
Benchmarking a USP30 inhibitor
In this Issue
Advertisement